MarketCapExport financials
Unilever PLC (UL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Unilever PLC Income Statement 2025-2011 | UL
Brief overview of profit and loss at Unilever PLC
The comparison covers a five-year financial horizon. Revenue reported by Unilever PLC was 50.7 billion euros at the beginning of the period and 50.5 billion euros at the end. The cumulative result was −0.4%, corresponding to roughly −0.1% per year. The scale of the core business was largely unchanged.
Gross profit changed from 22 billion euros to 23.7 billion euros (+7.6%). Revenue outpaced cost of revenue, allowing more sales to flow into gross profit. The gross margin was 43.5% at the start and 46.9% at the end. A wider margin shows that the economics of the core business improved.
Over the period, EBITDA shifted from 10.3 billion euros to 10.4 billion euros, a change of +0.7%. The operating result changed at a rate similar to sales. EBITDA margin was 20.3% at the start and 20.6% at the end. EBITDA as a share of revenue remained steady.
The net result moved from 5.6 billion euros to 10 billion euros, or +79.4%. The final year delivered the highest net income in the period.
Market value was 130 billion euros at the start and 140 billion euros at the end. The valuation did not keep pace with the reported progress.
Financial takeaway
The five-year picture requires weighing both strengths and weaknesses. The financial profile benefits from a steady EBITDA margin, a stronger final result and improving gross profitability. Caution is warranted because of weak sales momentum. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Unilever PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
140 B | 133 B | 109 B | 129 B | 129 B | 130 B | 131 B | 128 B | 125 B | 116 B | 126 B | 125 B | 111 B | 115 B | 93.9 B |
Shares |
2.18 B | 2.22 B | 2.24 B | 2.55 B | 2.6 B | 2.62 B | 2.62 B | 2.68 B | 2.8 B | 2.84 B | 2.84 B | 2.84 B | 2.84 B | 2.83 B | 2.88 B |
Historical Prices |
64 | 59.9 | 48.9 | 50.7 | 49.8 | 49.7 | 49.9 | 47.7 | 44.7 | 39.9 | 34.9 | 34.9 | 31.3 | 29.4 | 23.1 |
Net Income |
10 B | 6.37 B | 7.14 B | 8.27 B | 6.62 B | 5.58 B | 5.62 B | 9.39 B | 6.05 B | 5.18 B | 4.91 B | - | - | - | - |
Revenue |
50.5 B | 52.5 B | 51.7 B | 60.1 B | 52.4 B | 50.7 B | 52 B | 51 B | 53.7 B | 52.7 B | 53.3 B | - | - | - | - |
Cost of Revenue |
26.8 B | 28 B | 29.2 B | 35.9 B | 30.3 B | 28.7 B | 29.1 B | 28.7 B | 30.5 B | 30.2 B | 30.8 B | - | - | - | - |
Gross Profit |
23.7 B | 24.5 B | 22.5 B | 24.2 B | 22.2 B | 22 B | 22.9 B | 22.3 B | 23.2 B | 22.5 B | 22.5 B | - | - | - | - |
Operating Income |
9.04 B | 8.83 B | 9 B | 10.8 B | 8.7 B | 8.3 B | 8.71 B | 12.6 B | 8.96 B | 7.8 B | 7.52 B | - | - | - | - |
Interest Expense |
- | - | - | - | - | 1.19 B | - | - | - | - | - | - | - | - | - |
EBITDA |
10.4 B | 10.2 B | 10.1 B | 12.7 B | 10.5 B | 10.3 B | 10.7 B | 14.9 B | 11 B | 9.26 B | 8.76 B | - | - | - | - |
Operating Expenses |
14.7 B | 15.7 B | 13.5 B | 13.4 B | 13.5 B | 12.7 B | 14.2 B | 9.68 B | 14.3 B | 14.7 B | 15.1 B | 12.2 B | 13.2 B | 13.6 B | 12 B |
General and Administrative Expenses |
13.6 B | 14.3 B | 13.4 B | 14.5 B | 12.5 B | - | 8.51 B | 1.61 B | 5.84 B | 5.97 B | 5.94 B | 3.95 B | 13 B | 13.6 B | 12.1 B |
Annual performance
Select metrics to display
All numbers in EUR currency
Quarterly Income Statement Unilever PLC
| 2025-Q4 | 2025-Q2 | 2024-Q4 | 2024-Q2 | 2023-Q4 | 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
2.18 B | 2.46 B | 2.22 B | 2.5 B | 2.24 B | 2.52 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
10 B | 3.81 B | 6.37 B | 4.02 B | 7.14 B | 3.88 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
50.5 B | 15.4 B | 52.5 B | 16.1 B | 51.7 B | 15.7 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
26.8 B | - | 28 B | - | 29.2 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
23.7 B | - | 24.5 B | - | 22.5 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
9.04 B | 5.32 B | 8.83 B | 5.95 B | 9 B | 5.52 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
10.4 B | 6.16 B | 10.2 B | 6.74 B | 10.1 B | 6.27 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
14.7 B | - | 15.7 B | - | 13.5 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
13.6 B | - | 14.3 B | - | 13.4 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in EUR currency
The income statement is one of the three key financial reports of a company Unilever PLC (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
The Clorox Company
CLX
|
$ 106.6 | 1.01 % | $ 12.9 B |  USA |
 |
The Estée Lauder Companies
EL
|
$ 113.35 | 0.17 % | $ 41.1 B | USA |
 |
Colgate-Palmolive Company
CL
|
$ 98.06 | 0.12 % | $ 79.3 B | USA |
 |
The Procter & Gamble Company
PG
|
$ 168.81 | 0.29 % | $ 394 B | USA |
 |
United-Guardian
UG
|
$ 9.01 | 1.81 % | $ 41.4 M | USA |
 |
USANA Health Sciences
USNA
|
$ 13.1 | -5.42 % | $ 243 M | USA |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
Church & Dwight Co.
CHD
|
$ 111.77 | 0.41 % | $ 27.1 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 110.78 | -1.03 % | $ 36.8 B | USA |
 |
Hims & Hers Health
HIMS
|
$ 19.1 | -16.76 % | $ 4.3 B | USA |
 |
Coty
COTY
|
$ 4.34 | 2.73 % | $ 3.81 B | USA |
 |
e.l.f. Beauty
ELF
|
$ 118.5 | -0.71 % | $ 6.9 B | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.44 | -1.36 % | $ 7.84 M |  China |
 |
Helen of Troy Limited
HELE
|
$ 38.19 | 2.28 % | $ 878 M |  Bermuda |
 |
Newell Brands
NWL
|
$ 5.94 | 0.76 % | $ 2.48 B | USA |
 |
Acme United Corporation
ACU
|
$ 70.35 | 1.6 % | $ 266 M | USA |
 |
Edgewell Personal Care Company
EPC
|
$ 29.61 | 0.25 % | $ 1.41 B | USA |
 |
LifeVantage Corporation
LFVN
|
$ 4.64 | -12.29 % | $ 58.2 M | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 8.62 | -3.69 % | $ 16.4 M | USA |
 |
Inter Parfums
IPAR
|
$ 135.62 | -0.4 % | $ 4.35 B | USA |
 |
Nature's Sunshine Products
NATR
|
$ 10.89 | -1.23 % | $ 196 M | USA |
 |
Nu Skin Enterprises
NUS
|
$ 4.04 | -5.61 % | $ 199 M | USA |
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
Spectrum Brands Holdings
SPB
|
$ 88.66 | -0.75 % | $ 2.28 B | USA |